Lungen Lu

3.9k total citations
98 papers, 2.3k citations indexed

About

Lungen Lu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Lungen Lu has authored 98 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Epidemiology, 50 papers in Hepatology and 31 papers in Molecular Biology. Recurrent topics in Lungen Lu's work include Liver Disease Diagnosis and Treatment (49 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (21 papers). Lungen Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (49 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (21 papers). Lungen Lu collaborates with scholars based in China, United States and Germany. Lungen Lu's co-authors include Qingqing Zhang, Mingyi Xu, Ying Qu, Minde Zeng, Yimin Mao, Chunfang Gao, Qidi Zhang, Xiaobo Cai, Yuecheng Guo and Kun Zhou and has published in prestigious journals such as Hepatology, Scientific Reports and The FASEB Journal.

In The Last Decade

Lungen Lu

94 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lungen Lu China	27	1.1k	799	687	466	308	98	2.3k
Imad Nasser United States	25	1.6k 1.4×	1.2k 1.5×	531 0.8×	530 1.1×	285 0.9×	69	2.7k
Chuan Shen China	19	673 0.6×	562 0.7×	550 0.8×	532 1.1×	387 1.3×	71	1.9k
Xavier Verhelst Belgium	25	898 0.8×	692 0.9×	439 0.6×	425 0.9×	144 0.5×	104	1.8k
Archana Rastogi India	28	1.2k 1.1×	1.2k 1.5×	349 0.5×	679 1.5×	184 0.6×	168	2.5k
Hirotoshi Ebinuma Japan	29	1.2k 1.1×	1.1k 1.4×	579 0.8×	563 1.2×	161 0.5×	148	2.8k
Young‐Hwa Chung South Korea	33	1.4k 1.2×	1.6k 2.0×	660 1.0×	288 0.6×	302 1.0×	86	2.8k
Huiguo Ding China	28	1.1k 0.9×	1.0k 1.3×	756 1.1×	254 0.5×	450 1.5×	107	2.1k
Howard Monsour United States	19	868 0.8×	1.1k 1.4×	458 0.7×	618 1.3×	238 0.8×	41	2.3k
Dong Hyeon Lee South Korea	27	1.6k 1.4×	1.2k 1.5×	515 0.7×	335 0.7×	193 0.6×	129	2.6k
Francesco Tovoli Italy	29	1.5k 1.3×	1.3k 1.7×	384 0.6×	857 1.8×	312 1.0×	132	3.3k

Countries citing papers authored by Lungen Lu

Since Specialization

Citations

This map shows the geographic impact of Lungen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lungen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lungen Lu more than expected).

Fields of papers citing papers by Lungen Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lungen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lungen Lu. The network helps show where Lungen Lu may publish in the future.

Co-authorship network of co-authors of Lungen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lungen Lu. A scholar is included among the top collaborators of Lungen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lungen Lu. Lungen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Junjun, Guangwen Chen, Bo Shen, et al.. (2025). YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling. Cellular & Molecular Biology Letters. 30(1). 119–119.

Xue, Qian‐Li, Zhenyu Zhang, Xing Li, et al.. (2024). Efficacy and safety of tegoprazan (LXI-15028) vs. esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial. Chinese Medical Journal. 138(19). 2464–2471. 2 indexed citations

Zhang, Qingqing, et al.. (2024). Exploration of YBX1 role in the prognostic value and immune characteristics by single‐cell and bulk sequencing analysis for liver hepatocellular carcinoma. The Journal of Gene Medicine. 26(3). e3680–e3680. 3 indexed citations

Shen, Bo, Tianyi Gu, Cui Zhou, et al.. (2023). Escherichia coli Promotes Endothelial to Mesenchymal Transformation of Liver Sinusoidal Endothelial Cells and Exacerbates Nonalcoholic Fatty Liver Disease Via Its Flagellin. Cellular and Molecular Gastroenterology and Hepatology. 16(6). 857–879. 27 indexed citations

Zhang, Mengjie, et al.. (2023). Can vitamin B6 alleviate the adverse reactions of quadruple anti-Helicobacter pylori regimen? : randomized controlled trial. BMC Infectious Diseases. 23(1). 590–590. 1 indexed citations

Cui, Zhenyu, et al.. (2022). The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota. BMC Microbiology. 22(1). 321–321. 17 indexed citations

Lu, Jiawei, Jianbo Ni, Sumin Chen, et al.. (2022). RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24. Journal of Cancer. 13(9). 2781–2797. 5 indexed citations

Li, Binghang, Fei Li, Tianyi Gu, et al.. (2022). Specific knockdown of Y-box binding protein 1 in hepatic progenitor cells inhibits proliferation and alleviates liver fibrosis. European Journal of Pharmacology. 921. 174866–174866. 9 indexed citations

Zhang, Qingqing, Qidi Zhang, Binghang Li, et al.. (2021). The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B. Mediators of Inflammation. 2021(1). 6636947–6636947. 8 indexed citations

10.

Wang, Junjun, Wei Hu, Teng Liu, et al.. (2021). Dissecting the single-cell transcriptome underlying chronic liver injury. Molecular Therapy — Nucleic Acids. 26. 1364–1373. 16 indexed citations

11.

Xiao, Jingbo, et al.. (2020). Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma. BMC Gastroenterology. 20(1). 322–322. 1 indexed citations

12.

Zhang, Qingqing & Lungen Lu. (2015). Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy. Journal of Clinical and Translational Hepatology. 3(1). 78–84. 130 indexed citations

13.

Gao, Yueqiu, Wenhong Zhang, Ping Xu, et al.. (2015). [Cholestasis morbidity rate in first-hospitalized patients with chronic liver disease in Shanghai].. PubMed. 23(8). 569–73. 10 indexed citations

14.

Li, Fei, et al.. (2015). FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection. Biomedicine & Pharmacotherapy. 72. 103–108. 16 indexed citations

15.

Lu, Lungen. (2015). A 6 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis B. Frontiers in bioscience. 21(3). 479–486. 12 indexed citations

16.

Xu, Mingyi, et al.. (2014). Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C. Journal of Clinical and Translational Hepatology. 2(4). 222–7. 10 indexed citations

17.

Lu, Zhanjun, Lungen Lu, Qing Xia, et al.. (2014). MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia-inducible factor-2α pathway in vitro and in vivo. Molecular Medicine Reports. 10(5). 2401–2408. 24 indexed citations

18.

Zheng, Rui-dan, et al.. (2010). Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. International Journal of Medical Sciences. 7(5). 272–277. 46 indexed citations

19.

Zeng, Minde, Lungen Lu, Yimin Mao, et al.. (2005). Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model†. Hepatology. 42(6). 1437–1445. 139 indexed citations

20.

Yang, Wenzhuo, Minde Zeng, Yimin Mao, et al.. (2002). [Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis].. PubMed. 10(3). 193–6. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact